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A quinone-mediated two-electron gate is shared by Photosystem II (PS II) and the photosystem of purple bacteria. In the 
bacterial reaction center, electron transfer from the reduced primary quinone acceptor, QA, to the secondary quinone, QB, as 
well as the sensitivity of this electron transfer step to inhibition by terbutryn, are regulated by the H subunit of the reaction 
center. Sequential removal of three polypeptides (10 and 22, followed by 28 kDa) from 02 evolving PS II reaction center complex 
preparations impairs QB activity. Removal of the 22 kDa protein does not abolish the herbicide sensitivity of electron transfer 
mediated by an added p-benzoquinone, but another of these proteins, a species of 28 kDa that binds chlorophyll, appears to 
regulate the ability of the herbicide DCMU to interfere with PS II electron transfer (Bowlby, N.R. et al. (1990) Curr. Res. 
Photosynth. I, 539-542). In this communication, we show that exposure of PS II to Na-cholate yields a preparation in which 
substantial depletion of a 22 kDa intrinsic protein has occurred. In the depleted preparations, a hydrophilic oxidant (Fe(CN) 3-), 
rather than a lipophilic p-benzoquinone acceptor, supports the highest rates of 0 2 evolution in a reaction that shows little 
sensitivity to the QB inhibitor DCMU. Although this observation might indicate a disruption of QB function that is associated 
with removal of the 22 kDa protein, this is not the case. It is shown here that under some conditions, Na-cholate will modify the 
response of PS II to Fe(CN)63- without release of the 22 kDa protein. 
Introduction 
Primary charge separation in Photosystem II (PS II) 
is stabilized by secondary electron transfer events; the 
oxidized primary donor P6~0 is reduced by Yz, a tyro- 
sine residue on one of the constituent RC polypeptides 
[1,2] and the reduced primary acceptor pheophytin ( I - )  
is oxidized by a tightly bound quinone denoted QA [3]. 
The state Y~P680IQA subsequently decays; the man- 
ganese cluster of the O2-evolving complex is oxidized 
by Y~,  and an exchangeable quinone, QB is reduced 
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by Q~. A similar quinone-mediated electron transfer 
reaction occurs in photosynthetic bacteria and the crys- 
tal structures of the RCs of Rhodopseudomonas viridis 
[4,5] and Rhodobacter sphaeroides [6,7] are cited as 
tentative models for the structure of the quinone-bind- 
ing domain of the acceptor side of PS II [8]. In addition 
to QA and QB, an atom of non-heme iron is present in 
both PS II and bacterial RCs. Although the iron atom 
is not essential for electron transfer between the 
quinones in purple bacteria [9], it is normally coupled 
to the quinones through magnetic interactions that are 
revealed by EPR spectroscopy. 
Traditional inhibitors of electron transfer from QA 
to QB (DCMU in PS II or terbutryn in bacteria) 
compete with quinones at the QB site [10,11]. In bacte- 
ria, Terbutryn sensitivity is decreased upon removal of 
the H subunit, and then increased upon subsequent 
rebinding of this protein [12], suggesting that electron 
transfer on the reducing side of the photoreaction is 
influenced by this polypeptide. In PS II the QA and the 
QB sites are buried within the protein complex; the 
hydrophilic, anionic oxidant Fe(CN)63- is ineffective in 
272 
supporting high rates of activity. Native QB-site activity 
in PS II, consisting of DCMU-sensitive quinone-depen- 
dent electron transfer, is affected by proteolysis of 
thylakoid membranes with trypsin. After trypsin treat- 
ment, decreased sensitivity to DCMU inhibition is ac- 
companied by stimulation of Fe(CN)63--dependent 
electron transfer at the expense of p-benzoquinone- 
supported activity [13]. Purification procedures also 
produce alterations to herbicide-sensitive electron 
transfer activity. Highly-resolved PS II preparations 
incapable of 0 2 evolution activity retain one herbicide 
binding site per RC [14] but the herbicide inhibition 
constant (150) in such preparations is greatly reduced. 
Likewise, in highly-purified PS II preparations retain- 
ing the capacity for 0 2 evolution activity, Yamada et 
al. [15] found that DCMU-insensitive electron transfer 
was present, and that the highest rates of such activity 
were obtained with Fe(CN)63-, rather than a p-benzo- 
quinone, as the electron acceptor. 
Stepwise removal of intrinsic proteins from PS II 
has identified species that may function in regulation 
of PS II reducing side activity. Ghanotakis et al. [16] 
showed that a purified 0 2 evolving PS II preparation 
depleted of LHCII and 23 and 17 kDa extrinsic poly- 
peptides retained DCMU sensitive, quinone-catalyzed 
activity. Subsequent removal of 28, 22 and 10 kDa 
subunits from this preparation by gel filtration [17] 
created a preparation exhibiting DCMU-insensitive 
electron transfer. Sequential removal of these same 
subunits by ion-exchange chromatography (Ref. 18 and 
Bowlby, N.R. et al., data not shown) in detergent 
yielded a preparation with subunit composition and 
DCMU-insensitive activity similar to that reported by 
Yamada et al. One of the polypeptides (a 28 kDa 
Chl-binding species) removed by purification appears 
to have a function in PS II analogous to that of the 
bacterial H-subunit; selective removal of this species 
abolishes the ability of DCMU to interfere with DCBQ 
reduction [18]. While the 28 kDa subunit in PS II binds 
Chl a, and perhaps Chl b [19,20], the 22 and 10 kDa 
subunits appear to have no tightly-bound chro- 
mophores; the 10 kDa subunit has been suggested by 
Packham [21] to be the H-subunit analog in PS II 
based on similarities between the primary sequence of 
the plastid encoded psbH gene product [22] and two 
bacterial H-subunits. 
Here, we describe a method for the selective deple- 
tion of the 22 kDa PS II subunit by treatment of the 
O2-evolving PS II RC complex with Na-cholate. Other 
investigators have shown that cholate affects the oxidiz- 
ing side of PS II by extracting extrinsic polypeptides 
[30]. The results presented in this communication show 
that in addition to 22 kDa protein removal, Na-cholate 
can provoke a DCMU-insensitive Fe(CN) 3- reduction 
reaction in PS II. At the same time electron transfer 
catalyzed by a p-benzoquinone acceptor, which is more 
closely related to QB site integrity, remains sensitive to 
inhibition by DCMU after removal of the 22 kDa 
species. 
Materials and Methods 
PS II membranes and O2-evolving PS II RC-com- 
plexes were prepared as described in Ref. 16 to yield 
material with high rates of O 2 evolution (> 1600 tzmol 
O2/mg Chl per h). Cholic acid was recrystallized twice 
from ethanol. A 10% (w/v) solution at pH 7.0 was 
prepared as the sodium salt and was filtered through a 
0.2 /zM filter before use. Cholate treatment of RC 
complexes (0.25 mg Chl/ml) or PS II membranes (1 mg 
Chl/ml) was carried out at 4°C in the dark for thirty 
min. with occasional gentle mixing. Preliminary experi- 
ments were conducted with the RC complex to opti- 
mize the detergent and salt conditions which led to the 
greatest change in quinone-dependent activity with 
minimal inhibition of 0 2 evolution activity. For the 
experiments reported here, PS II preparations in SMC 
(0.4 M sucrose, 50 mM Mes-NaOH (pH 6.0), 20 mM 
CaC12) were exposed to 2.5% Na-cholate and 250 mM 
NaC1 by additions from 10% and 4 M stock solutions 
respectively. Incubation mixtures were centrifuged at 
40 000 × g for 30 min, washed once in SMC at 0.25 mg 
Chl/ml (RC preparations) or 1.0 mg Chl/ml (PS II 
membranes) and resuspended in SMC to 1 mg Chl/ml 
(RC preparations) or 3 mg Chl/ml (PS II membranes) 
with a paintbrush before being frozen and stored at 
-60°C. The cholate extract was dialyzed overnight at 
10°C against 200 volumes of 20 mM Mes-NaOH (pH 
6.0). Precipitated material was then recovered by cen- 
trifugation at 40 000 x g for 30 min. and resuspended 
in a small amount of SMC. 
Antibodies were raised in a rabbit following stan- 
dard procedures by using electrophoretically pure 22 
kDa protein as antigen prepared as follows. After 
separation of SDS-denatured RC complex proteins on 
a 15% acrylamide gel as described in Ref. 16, the band 
containing the 22 kDa protein was excised from the 
gel, frozen in liquid N 2 and pulverized with a mortar 
and pestle under liquid N 2. Protein was extracted into 
25 mM Tris-HC1 (pH 7.5) with 0.1% SDS by several 
rounds of resuspension of the frozen gel powder in 
excess buffer followed by incubation at room tempera- 
ture for 15 min and centrifugation to compact the 
swollen gel particles. The extracts were combined and 
concentrated by vacuum dialysis. A second preparative 
gel with 12.5% acrylamide and 6 M urea resolved 
additional proteins, and the extraction of pure 22 kDa 
protein was repeated with liquid N 2 as just described. 
Pre-immune serum was collected and a portion of the 
protein solution (200-500 tzg) was emulsified with 
complete Freund's adjuvant in a 1 : 1 ratio and injected 
(intramuscular) at four sites (250/zl each) on the upper 
thighs of a young white rabbit. After six weeks, whole 
blood was collected and the animal was given another 
set of injections by using the purified protein in an 
emulsion with Freund's incomplete adjuvant. Portions 
of whole serum were stored at - 60°C. 
For analysis of PS II subunit composition before and 
after cholate treatment, SDS-PAGE was carried out by 
using 13.5% acrylamide and 4 M urea. Protein bands 
were visualized by staining with Coomassie brilliant 
blue or Western blotting to nitrocellulose followed by 
immune decoration. Primary antibodies were allowed 
to bind to Western blots overnight by shaking in TTBS 
(TBS with 0.05% Tween-20) at a typical dilution of 
1 : 1000 for whole serum. The blot was washed (3 × 10 
min) in TTBS and secondary antibody (Goat anti-rab- 
b i t /HRP conjugate, Bio-Rad) was allowed to bind at 
room-temperature in TTBS for 1-2 h. followed by 
3-times 10-min washes in TBS to remove Tween-20 
and unbound secondary antibody. Antigen-antibody 
complexes were visualized by development with HRP 
Color Development Reagent (Bio-Rad) according to 
the manufacturer's instructions. 
For cyt b559 determinations, O2-evolving PS II RC 
complex or cholate-treated RC complex preparations 
(0.5 mg Chl/ml) were solubilized with DM added from 
a 10% stock solution. For the RC complex, the final 
DM concentration was 0.5%; for the cholate-treated 
RC complex, the final concentration of DM was 1.0%. 
After addition of DM, samples were diluted with 50- 
100 vols. SMC for spectrophotometry. The amount of 
cyt b559 was estimated from the dithionite-reduced 
minus Fe(CN) 3--oxidized difference spectrum by using 
17.5 mM -1 cm -t  as the differential extinction coeffi- 
cient at 559 nm [23]. The Chl concentration was deter- 
mined following dilution of 0.5 ml of sample with 2 ml 
acetone by using the extinction coefficients of Arnon 
[24]. 
Steady-state rates of 0 2 evolution were measured in 
a Clark type electrode at 25°C. The assay mixture (1.6 
ml) contained 50 mM Mes-NaOH (pH 6.0), 20 mM 
CaC12 and electron acceptors as described in the figure 
legends; DCMU was added from a stock solution in 
methanol to the final concentrations indicated. Esti- 
mates of Vma x for 0 2 evolution and the Kn, for 
Fe(CN)~- were made by a weighted regression analysis 
[25] modified to run under BASIC on an IBM-XT 
compatible desktop computer. Plastoquinone quantifi- 
cation was performed as in Ref. 26. Room-temperature 
EPR spectroscopy was performed by using a Bruker 
ER-200D spectrometer fitted with a TM cavity. Instru- 
ment settings and experimental conditions are de- 
scribed in Results and the figure legends. 
Results 
Fig. 1 presents an electrophoretic analysis of the 
constituent polypeptides in native RC complex and 
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Fig. 1. Removal of 22 kDa protein by cholate treatment. A 
Coomassie-stained gel (left) and Western blot challenged with anti- 
22-kDa serum (right) are shown. Lanes A and D contain O2-evolving 
PS II RC complex preparations before and after (Lanes B and E) 
treatment with Na-cholate and the supernatant fluid following dialy- 
sis as described in Materials and Methods (Lane C). 
cholate-treated material, as well as proteins recovered 
from the dialyzed supernatant produced by cholate 
treatment. The major polypeptides released by cholate 
treatment include the 22 kDa intrinsic protein and, to 
substantially lesser extents, 47, 28 and 10 kDa proteins 
(Lane C). Lanes D and E show a Western blot probed 
with polyclonal antiserum directed against the 22 kDa 
species. The RC complex (Lane D) shows a strong 
signal corresponding to the 22 kDa protein; little reac- 
tivity is seen in the cholate-treated preparation (Lane 
E). Optical absorption spectra of the cholate-treated 
RC complex and an untreated sample are nearly iden- 
tical (not shown) confirming that little pigment was 
extracted. Table I presents data on analyses of chro- 
mophore content before and after cholate extraction. 
Hydroquinone-reducible, high-potential b559 was  not 
detected in either preparation, although about 30% 
and 10% of the total b559 was reduced by ascorbate 
before and after cholate treatment (not shown). The 
data of Table I and Fig. 1 confirm that negligible 
amounts of pigment-binding proteins are lost from PS 
II as a result of cholate treatment. 
A comparison of the effect of cholate treatment on 
electron transport in the RC complex and PS II mem- 
branes is also summarized by data presented in Table 
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TABLE I 
Effects of cholate treatment on component stoichiometries and activi- 
ties of the PS H RC complex and BBY membranes 
RC complex Membrane  sheets  
- Cholate + Cholate - Cholate + Cholate 
C h l / 2  b559 65 +_ 3 65 + 3 275 _+ 25 275 + 25 
M n / R C  a,b 4 4 4 n.d. c 
P Q - 9 / R C  2.2_+ 0.1 1.9_+ 0.1 3.2-+ 0.01 n.d. 
VmaxDCBQd 2464 -+144 1082 -+39 920 +68  382_+17 
K m ( ~ M )  92 _+ 9 53 _+ 4 80 -+10 30_+10 
V m a x  
Fe(CN) 3-  732 _+27 1298 _+28 56 + 4 203+_ 3 
K m (/xM) 125 -+ 16 181 -+12 34 _+15 113_+ 4 
a Assuming two cytochromes bss 9 per O2-evolving RC. 
b Nearest  integer. 
c n.d., not determined. 
d Expressed a s /xmol  0 2 / m g  Chl per h. 
I. After cholate exposure, both preparations show an 
enhanced capacity for Fe(CN) 3- reduction. In contrast 
to the activity seen in the cholate-treated RC complex, 
however, cholate-treated PS II membranes still reduce 
DCBQ at higher rates than can be obtained with 
Fe(CN) 3-. The interaction between DCBQ and 
Fe(CN) 3- in supporting 02 evolution activity can be 
seen in Fig. 2 for untreated (top) and cholate-treated 
(bottom) RC complexes. After cholate treatment, two 
differences are observed with respect to the effects of 
DCBQ addition on Fe(CN)63- reduction. First, the 
increase in activity with DCBQ occurs only at low 
concentrations of the quinone; higher DCBQ concen- 
trations are inhibitory. Second, the Vma x for Fe(CN) 3- 
reduction (after correcting for DCBQ-dependent activ- 
ity) is significantly increased at all DCBQ concentra- 
tions when compared to the Vma x for Fe(CN)63- reduc- 
tion in the native RC complex. 
Effects of cholate treatment on the kinetics of 
Fe(CN)36--dependent 0 2 evolution at increasing con- 
centrations of DCBQ are presented as double-recipro- 
cal plots in Fig. 3. Activity due to DCBQ alone was 
subtracted from the observed rate in order to reveal 
the kinetics for Fe(CN)3--dependent activity. In the 
untreated RC complex Fig. 2A) DCBQ inhibition of 
Fe(CN)36--supported activity is competitive, indicating 
that the QB site provides the major pathway for 
Fe(CN) 3- reduction. In addition, lower concentrations 
of DCBQ (< 50 /zM) decrease the g m for Fe(CN) 3- 
reduction while higher concentrations have the oppo- 
site effect. 
Fig. 3B shows a similar analysis of the cholate- 
treated RC complex. These data show the synergistic 
effect of the electron acceptors only at concentrations 
lower than 50 /~M DCBQ. At concentrations lower 
than 50 p.M the effect of added DCBQ is to decrease 
K m and Vma x, whereas in the untreated RC complex, 
the effect is to decrease K m and increase Vm~. Fur- 
thermore, the type of DCBQ inhibition of Fe(CN) 3- 
reduction is changed, becoming noncompetitive as the 
concentration of the quinone is increased. These re- 
sults indicate that cholate treatment has produced a 
significant modification to the QA-Fe-QB domain on 
the reducing side of PS II; these changes are reflected 
in a 30% reduction in steady-state 0 2 evolving activity 
(Table I). 
To analyze other alterations in the QB site, experi- 
ments were carried out in the presence of DCMU. The 
insets in Fig. 3 show the effect of 6.25 IzM DCMU on 
the kinetics of Fe(CN) 3- reduction in the absence 
(solid line) and presence (dashed line) of 125 ~M 
DCBQ. In control preparations, DCMU is a competi- 
tive inhibitor at the QB site regardless of whether 
Fe(CN)36- or DCBQ is the electron acceptor. Addition 
of DCMU also changes the type of inhibition by DCBQ, 
becoming uncompetitive with respect to Fe(CN) 3- re- 
duction. Following cholate treatment, 6.25/~M DCMU 
is a less potent inhibitor of Fe(CN)36--dependent activ- 
ity, but the inhibition of this activity by DCBQ remains 
noncompetitive. These cholate-induced changes in ac- 
ceptor reduction kinetics in the presence of DCMU 
provide strong evidence for a substantial alteration of 
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Fig. 2. Oxygen-evolution activity before and after cholate t reatment .  
Velocity vs. [Fe(CN)63-] plots are presented for the PS II RC 
complex (top) and cholate-treated RC complex (bottom) at various 
DCBQ concentrations. Activity is expressed in p.mol 0 2 / m g  Chl 
per h. Symbols show experimental data (average of three experi- 
ments)  and solid curves show model equations determined by the 
H Y P E R O  program [25]. Symbols represent  data at DCBQ concen- 
trations of (/~M): 0, I ;  6.25, e; 12.5, A; 25, [] 50, ©; 125,zx. The 
Chl concentration was 5 p .g /ml  for all assays. 
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Fig. 3. Inhibition of ferricyanide-dependent O2-evolution activity by 
DCBQ. The figure shows double-reciprocal plots of Fe(CN)63--de - 
pendent Oz-evolution activity at different concentrations of DCBQ 
in untreated PS II RC complex (A) and following cholate treatment 
(B). Symbols as in Fig. 2. The insets show double-reciprocal plots of 
Fe(CN)3--dependent O2-evolving activity without (squares) and with 
(circles) 125 #M DCBQ in the presence of 6.25/zM DCMU (activi- 
ties in the absence of Fe(CN)63- were 185 and 266/zmol 0 2 /mg Chl 
per h for the untreated and treated RC complex, respectively). Other 
experimental conditions as in Fig. 2. 
the quinone-iron acceptor complex which is charac- 
terized by a diminished interaction of acceptors with 
the QB site. The results are consistent with the 
cholate-induced appearance of a new site of acceptor 
reduction prior to the QB site. 
To investigate possible damage by cholate to donor 
side components of PS II, room-temperature EPR 
spectroscopy was carried out to examine the properties 
of Y~ and Y~. Measurement of the intensity of the 
low field peak in the derivative spectrum (denoted by 
the arrow in Fig. 4) provides a convenient means of 
quantifying the abundance of tyrosine radicals in PS II 
provided a standard with a known concentration of 
spins is available. The PS II membrane preparation has 
been well-characterized with respect to tyrosine radi- 
cals [27], and was used as the spin standard in these 
studies. Fig. 4 shows spectra in the g = 2 region for the 
RC complex and cholate-treated complex. The Chl 
concentration in each sample was adjusted to provide 
nearly equivalent RC concentrations based on cyt b559 
determinations and the spectra have been normalized 
with respect to spectrometer gain. This allows a direct 
comparison of the dark and light-induced signals shown 
in the figure. In the untreated RC complex, very little 
signal increase is observed under continuous illumina- 
tion, showing that reduction of Y~ is rapid. Following 
cholate treatment, about half of the signal attributed to 
Yt~ is observed, when compared to the untreated con- 
trol. Under continuous illumination, the signal inten- 
sity nearly doubles even though higher rates of 
Fe(CN)63--supported O2-evolution activity are ob- 
served. This indicates that the dark stability of Y~ has 
been affected; the radical is restored to full intensity 
on illumination. Another signal is present following 
long-term dark adaptation in the cholate-treated RC 
complex that is not seen in the untreated RC complex. 
This signal persists during illumination, but decays in 
the dark. The spectrum taken after 15 min of incuba- 
tion in the dark following illumination shows a well 
resolved Yt~ spectrum with little evidence of the other 
g = 2 radical, which could be regenerated by a second 
illumination (not shown). These results suggest that 
after exposure to cholate, subtle changes have occurred 
on the donor side of PS II that influence the stability 
or EPR properties of Yt~. The treatment also leads to 
the appearance of an as yet unidentified EPR signal 
that disappears following illumination. 
J" " RCComp ,x 
Q = rT' 
8G . .  >.\WiP' 
~ , ~ e l  ~/# Cholate-treated 
i ~ i  ~ ' '  ~'''~''', 't RC Complex 
g = 2,0045 
Fig. 4. Room temperature EPR spectra of the PS I I  RC complex 
before and after treatment with cholate. The dotted spectra were 
recorded following several hours of dark incubation of the sample on 
ice and solid spectra were acquired under continuous il lumination of 
the sample in the EPR cavity. The dashed spectra were recorded 
following a 15-rain incubation in the dark after i l lumination was 
terminated. Chlorophyll concentration was 2.] mg /m l  for both sam- 
pies and ] mM Fe(CN)~- was present. Spectrometer conditions as 
follows: Microwave frequency, 9.8 GHz; power, 10 roW; modulation 
amplitude, 8 Gpp. 
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Discussion 
Previous investigations of the effect of cholate on PS 
II activity have emphasized the ability of the detergent 
to extract polypeptides that influence electron transfer 
reactions on the oxidizing side of PS II [28-31]. As we 
show here, cholate treatment also alters electron trans- 
fer through the iron-quinone complex of PS II; mini- 
mal effects on steady-state electron transfer events at 
the site of 0 2 evolution are observed when assays are 
conducted in the presence of a saturating amount of 
CaCI 2. Cholate treatment under our conditions in- 
duces a selective extraction of a 22 kDa protein, but 
produces little change in chromophore and manganese 
abundance (Table I). It should be noted that the 
amount of cholate used in the experiments with the 
RC complex presented here was 75-fold greater on a 
RC basis than was used in a previous study with 
thylakoid membranes [30]. Nevertheless, the O2-evolv- 
ing complex remains intact as evidenced by retention 
of the 33 kDa protein, high rates of activity, and 
EPR-silent manganese. Based on two cyt b559 per 
O2-evolving center, our quantification of other species 
reveal the presence of about four EPR-silent man- 
ganese, 65-75 Chl, and two plastoquinones in cholate- 
extracted material. These data would suggest that the 
decrease in O2-evolution activity most likely arises from 
alterations in the rate constants for acceptor reduction 
following detergent exposure. 
Our data show that the interaction between DCBQ 
and Fe(CN) 3- in the native RC complex is consistent 
with a model in which the quinone is the preferred 
oxidant of the QB site; in the presence of both accep- 
tors the preferred path of electron transfer is from the 
Q~ site to DCBQ. Ferricyanide acts primarily as an 
electron sink that maintains a nearly constant supply of 
the oxidized lipophilic acceptor, and only secondarily 
as a direct oxidant of the QB site. These effects of 
Fe(CN) 3- are apparent in the experiments of Fig. 2, 
where addition of small amounts of DCBQ affect the 
apparent K m of Fe(CN)36 -, and in our observations 
that in all experiments with DCBQ, addition of 
Fe(CN)36 - increased the rate of electron transfer sup- 
ported by the quinone acceptor. 
Steady-state kinetic analyses of DCBQ and Fe 
(CN)63- reduction in the untreated RC complex, with 
and without the inhibitor DCMU, show that the domi- 
nant pathway for reduction of both acceptors includes 
the QB site, although another site of much lower 
activity is also present. Similar kinetic analyses follow- 
ing cholate treatment show that the interactions of 
Fe(CN) 3- and DCBQ with the reducing side of PS II 
have been altered which suggests that an electron 
transfer pathway has been created on the reducing side 
of the photoreaction. The newly-created site of accep- 
tor reduction is characterized by DCMU insensitivity, 
more efficient reduction of Fe(CN)63-, and by a dimin- 
ished capacity for DCBQ reduction (Figs. 2 and 3). 
Cholate produces similar, but less dramatic changes in 
PS II membrane preparations (Table I). On account of 
the substantial loss of DCMU sensitivity and the in- 
crease in Fe(CN)36--catalyzed activity, we are led to 
conclude that cholate binding a n d / o r  loss of the 22 
kDa protein modify the structure and redox activity of 
the iron-quinone complex in PS II. 
We suggest that the former is the case based on 
reconstitution experiments with the 22 kDa protein 
and cholate-treated RC complexes that were unsuc- 
cessful in restoring native QB activity. Although recon- 
stitution conditions were chosen to minimize loss of 0 2 
evolution, the 22 kDa protein did not rebind at all, 
probably the result of irreversible aggregation of the 
protein following removal and dialysis. The hydropathy 
profile of the 22 kDa protein predicted from the psbS 
gene sequence [32] suggests up to four membrane 
spanning helices, which could account for the difficulty 
in achieving successful reconstitution. In addition, this 
sequence shows no similarities with bacterial H-sub- 
units [32,33]. Results presented in Ref. 18 also argue 
against the involvement of the 22 kDa protein in the 
regulation of electron transfer. Finally, experiments 
with PS II membranes indicate that alterations to the 
reducing side are also seen following cholate treat- 
ment. These changes are not accompanied by loss of 
the 22 kDa protein. 
In summary, we would conclude that cholate treat- 
ment of PS II induces more substantial changes in 
electron transfer than previously suspected. In contrast 
to the previously reported release of extrinsic poly- 
peptides [28,30], we show here that in both PS II 
membranes and in RC complex preparations, the de- 
tergent can alter acceptor reduction, herbicide sensitiv- 
ity, and extract substantial amounts of the 22 kDa 
protein. Although treatment of purified PS II com- 
plexes with cholate alters acceptor reduction, sensitiv- 
ity of electron transfer to DCMU is only attenuated, 
but not abolished. From the data now available, it is 
clear that the 22 kDa protein is a tightly-bound compo- 
nent of PS II, but further experimentation is required 
to define its function in relation to other detergent 
extractable species. 
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